Midatech Pharma Plcの価格/販売
Midatech Pharma Plcの価格/販売は何ですか。
Midatech Pharma Plcの価格/販売は2.51です。
価格/販売の定義は何ですか。
価格対売上比率は、収益と比較した会社の株価です。
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
LSEのセクタHealth Careにおける価格/販売の企業と比べるMidatech Pharma Plc
Midatech Pharma Plcは何をしますか。
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Midatech Pharma Plcと類似の価格/販売
- Kingstonの価格/販売は2.51です。
- Cadila Healthcareの価格/販売は2.51です。
- Aberdeen Emerging Markets Investment Coの価格/販売は2.51です。
- Pantheon International Plcの価格/販売は2.51です。
- BHPの価格/販売は2.51です。
- Finjanの価格/販売は2.51です。
- Midatech Pharma Plcの価格/販売は2.51です。
- Bachem AGの価格/販売は2.51です。
- Exasol AGの価格/販売は2.51です。
- Tikkurila Oyjの価格/販売は2.51です。
- Mirum Pharmaceuticals Incの価格/販売は2.51です。
- Mayur Uniquotersの価格/販売は2.51です。
- 123869の価格/販売は2.51です。